- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Devyser Diagnostics AB (DVYSR)
Devyser Diagnostics AB stock price live, this page displays ST DVYSR stock exchange data. View the DVYSR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Devyser Diagnostics AB real time stock price chart below.
What Is the Devyser Diagnostics AB Stock Price Today?
The Devyser Diagnostics AB stock price today is 108.80.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is ""DVYSR.""
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Devyser Diagnostics AB a Good Stock to Buy?
Determining whether Devyser Diagnostics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVYSR quote. (ISIN: SE0016588867)
What Is the Devyser Diagnostics AB Stock Price Today?
The Devyser Diagnostics AB stock price today is 108.80.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is ""DVYSR.""
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Devyser Diagnostics AB a Good Stock to Buy?
Determining whether Devyser Diagnostics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVYSR quote. (ISIN: SE0016588867)
Stockholm
Currency in SEK
108.80
-2.80(-2.51%)
Closed·
Fair Value
An estimate of a Devyser Diagnostics AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
108.20
113.20
52 wk Range
83.30
159.60
DVYSR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Devyser Diagnostics AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
108.20113.20
52 wk Range
83.30159.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DVYSR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Devyser Diagnostics AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
156.09
Upside
+43.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Devyser Diagnostics AB Company Profile
Devyser Diagnostics AB (publ) engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides software programs for data processing and analysis, as well as interpretation of test results; and Amplicon Suite and Advyser software programs to screen markers and follow up samples for the same patient. Devyser Diagnostics AB (publ) was incorporated in 2004 and is based in Årsta, Sweden.
Devyser Diagnostics AB Earnings Call Summary for Q3/2025
- Devyser reported 20% revenue growth to SEK 56M in Q3 2025, but missed forecast of SEK 72.17M, causing stock to plunge 17.26% to SEK 102.6
- Company achieved positive EBIT of SEK 1.3M (vs. -SEK 22M last year) and improved gross margin to 75%, demonstrating operational efficiency gains
- Direct sales channel showed strong performance, particularly in Americas with 87% quarter-over-quarter growth; cash position stands at SEK 85M
- CEO Jan Wahlström emphasized focus on 'turning around the company to profitability' despite revenue miss against analyst expectations
- Management maintains 30% long-term growth target with focus on transplantation and hereditary diseases, expecting stronger H2 sales compared to H1
Last Updated: 05/11/2025, 10:10
Read Full TranscriptCompare DVYSR to Peers and Sector
Metrics to compare | DVYSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDVYSRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −71.9x | −1.4x | −0.6x | |
PEG Ratio | −1.08 | −0.03 | 0.00 | |
Price/Book | 5.3x | 3.2x | 2.6x | |
Price / LTM Sales | 7.5x | 6.9x | 3.3x | |
Upside (Analyst Target) | 42.5% | 91.5% | 41.4% | |
Fair Value Upside | Unlock | 23.7% | 6.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 156.09
(+43.46% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.17 / 0.27
Revenue / Forecast
56.40M / 72.17M
People Also Watch
FAQ
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is "DVYSR."
What Is the Devyser Diagnostics AB Market Cap?
As of today, Devyser Diagnostics AB market cap is 1.81B.
What Is Devyser Diagnostics AB's Earnings Per Share (TTM)?
The Devyser Diagnostics AB EPS (TTM) is -1.53.
When Is the Next Devyser Diagnostics AB Earnings Date?
Devyser Diagnostics AB will release its next earnings report on 11 Feb 2026.
From a Technical Analysis Perspective, Is DVYSR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Devyser Diagnostics AB Stock Split?
Devyser Diagnostics AB has split 0 times.
How Many Employees Does Devyser Diagnostics AB Have?
Devyser Diagnostics AB has 108 employees.
What is the current trading status of Devyser Diagnostics AB (DVYSR)?
As of 04 Dec 2025, Devyser Diagnostics AB (DVYSR) is trading at a price of 108.80, with a previous close of 108.80. The stock has fluctuated within a day range of 108.20 to 113.20, while its 52-week range spans from 83.30 to 159.60.
What Is Devyser Diagnostics AB (DVYSR) Price Target According to Analysts?
The average 12-month price target for Devyser Diagnostics AB is SEK156.08886934, with a high estimate of SEK169.19049714 and a low estimate of SEK144.41267048. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +43.46% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.